- IAGES
- ASI — Association of Surgeons of India
- SAGES
- International surgical societies
Quick answer
AI & snippet readyMuscle Loss After Newer Obesity Management Medicines (GLP-1 RA): Causes, Risks, Prevention, and Clinical Guidance Introduction The introduction of newer obesity management medicines, especially GLP-1 receptor agonists (GLP-1 RA) such as Semaglutide and dual agonists like Tirzepatide, has transformed obesity treatment worldwide. These medicines can produce remarkable weight loss, improve diabetes, reduce fatty liver disease, […]




Comments
Be the first to share your thoughts on this article.